Patients with aggressive B-cell lymphoma receiving CAR T-cell therapy have a low rate of severe infections despite lack of universal antibacterial and antifungal prophylaxis

1. Pernas, B.
2. Iacoboni, G.
3. Los-Arcos, I.
4. Carpio, C.
5. Márquez-Algaba, E.
6. Sanchez-Salinas, M.A.
7. Albasanz, A.
8. Esperalba, J.
9. Viñado, B.
10. Camps, I.R.
11. Barba, P.